Table 1.

Clinical information on the cohort.

Sample collection
PatientClinical findings at birthAntiviral regimeClinical findings at follow-upTime pointCompartmentViral load (IU/mL)
1Poor motility, germinolysisNoneNo symptoms0 MSaliva2.6 × 109
3 MBlooda2.5 × 101
SalivaNE
Urine4.0 × 106
6 MBlooda2.1 × 102
SalivaNE
Urine2.8 × 106
12 MBlooda1.2 × 101
SalivaNE
Urine9.6 × 105
2IUGR, low platelet count, hepatitis, poor motilityGCV, vGCVSNHL, hypotonia, tremors0 MBlood2.7 × 104
Saliva2.4 × 108
Urine6.9 × 106
3 MBlooda1.2 × 101
Saliva7.2 × 109
Urine8.4 × 106
6 MBlooda1.2 × 102
SalivaNE
Urine4.1 × 105
12 MBlooda2.4 × 101
SalivaNE
Urine1.5 × 103
3AsymptomaticNoneNo symptoms0 MBlood8.4 × 104
Saliva2.4 × 108
Urine5.2 × 106
3 MBlood2.2 × 102
SalivaNE
Urine2.3 × 106
6 MBlooda8.7 × 101
SalivaNE
Urine6.2 × 106
12 MBlooda1.2 × 101
SalivaaNE
Sample collection
PatientClinical findings at birthAntiviral regimeClinical findings at follow-upTime pointCompartmentViral load (IU/mL)
1Poor motility, germinolysisNoneNo symptoms0 MSaliva2.6 × 109
3 MBlooda2.5 × 101
SalivaNE
Urine4.0 × 106
6 MBlooda2.1 × 102
SalivaNE
Urine2.8 × 106
12 MBlooda1.2 × 101
SalivaNE
Urine9.6 × 105
2IUGR, low platelet count, hepatitis, poor motilityGCV, vGCVSNHL, hypotonia, tremors0 MBlood2.7 × 104
Saliva2.4 × 108
Urine6.9 × 106
3 MBlooda1.2 × 101
Saliva7.2 × 109
Urine8.4 × 106
6 MBlooda1.2 × 102
SalivaNE
Urine4.1 × 105
12 MBlooda2.4 × 101
SalivaNE
Urine1.5 × 103
3AsymptomaticNoneNo symptoms0 MBlood8.4 × 104
Saliva2.4 × 108
Urine5.2 × 106
3 MBlood2.2 × 102
SalivaNE
Urine2.3 × 106
6 MBlooda8.7 × 101
SalivaNE
Urine6.2 × 106
12 MBlooda1.2 × 101
SalivaaNE
a

Sequencing library not generated.

Abbreviations: 0 M, within 3 weeks; 3 M, 3 months; 6 M, 6 months; 12 M, 12 months; GCV, ganciclovir; vGCV, valganciclovir; IUGR, intrauterine growth restriction; SNHL, sensorineural hearing loss; NE, viral load not estimated.

Table 1.

Clinical information on the cohort.

Sample collection
PatientClinical findings at birthAntiviral regimeClinical findings at follow-upTime pointCompartmentViral load (IU/mL)
1Poor motility, germinolysisNoneNo symptoms0 MSaliva2.6 × 109
3 MBlooda2.5 × 101
SalivaNE
Urine4.0 × 106
6 MBlooda2.1 × 102
SalivaNE
Urine2.8 × 106
12 MBlooda1.2 × 101
SalivaNE
Urine9.6 × 105
2IUGR, low platelet count, hepatitis, poor motilityGCV, vGCVSNHL, hypotonia, tremors0 MBlood2.7 × 104
Saliva2.4 × 108
Urine6.9 × 106
3 MBlooda1.2 × 101
Saliva7.2 × 109
Urine8.4 × 106
6 MBlooda1.2 × 102
SalivaNE
Urine4.1 × 105
12 MBlooda2.4 × 101
SalivaNE
Urine1.5 × 103
3AsymptomaticNoneNo symptoms0 MBlood8.4 × 104
Saliva2.4 × 108
Urine5.2 × 106
3 MBlood2.2 × 102
SalivaNE
Urine2.3 × 106
6 MBlooda8.7 × 101
SalivaNE
Urine6.2 × 106
12 MBlooda1.2 × 101
SalivaaNE
Sample collection
PatientClinical findings at birthAntiviral regimeClinical findings at follow-upTime pointCompartmentViral load (IU/mL)
1Poor motility, germinolysisNoneNo symptoms0 MSaliva2.6 × 109
3 MBlooda2.5 × 101
SalivaNE
Urine4.0 × 106
6 MBlooda2.1 × 102
SalivaNE
Urine2.8 × 106
12 MBlooda1.2 × 101
SalivaNE
Urine9.6 × 105
2IUGR, low platelet count, hepatitis, poor motilityGCV, vGCVSNHL, hypotonia, tremors0 MBlood2.7 × 104
Saliva2.4 × 108
Urine6.9 × 106
3 MBlooda1.2 × 101
Saliva7.2 × 109
Urine8.4 × 106
6 MBlooda1.2 × 102
SalivaNE
Urine4.1 × 105
12 MBlooda2.4 × 101
SalivaNE
Urine1.5 × 103
3AsymptomaticNoneNo symptoms0 MBlood8.4 × 104
Saliva2.4 × 108
Urine5.2 × 106
3 MBlood2.2 × 102
SalivaNE
Urine2.3 × 106
6 MBlooda8.7 × 101
SalivaNE
Urine6.2 × 106
12 MBlooda1.2 × 101
SalivaaNE
a

Sequencing library not generated.

Abbreviations: 0 M, within 3 weeks; 3 M, 3 months; 6 M, 6 months; 12 M, 12 months; GCV, ganciclovir; vGCV, valganciclovir; IUGR, intrauterine growth restriction; SNHL, sensorineural hearing loss; NE, viral load not estimated.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close